Astrazeneca Share Discussion Threads

[steeplejack] 27/7/2017 08:17

You know how the drug industry works.

[montyhedge] 27/7/2017 08:12

Lol, buying what?

[steeplejack] 27/7/2017 08:10

Bid rumours?

[eggbird] 27/7/2017 08:10

Oouuucchhhh

[montyhedge] 27/7/2017 08:08

Back below £40, coming months.

[montyhedge] 27/7/2017 07:55

Not good opening coming.

[philanderer] 21/7/2017 09:57

Sold half.

[steeplejack] 16/7/2017 10:04

Closed around £51-70 equivalent at current xrates in New York.

[bluemango] 14/7/2017 23:00

Should bounce on Monday, especially as RSI was heading to oversold.

[bluemango] 14/7/2017 22:58

14 JULY 2017 • 9:10PM
Pascal Soriot will remain at FTSE 100 pharmaceuticals firm AstraZeneca, sources said on Friday, rebuffing rumours that he was planning a move to rival Israeli drugs giant Teva Pharmaceuticals.

Mr Soriot will host a call with analysts on AstraZeneca's second-quarter earnings at the end of the month as planned, AstraZeneca said.

A spokesman for AstraZeneca said the company never commented on speculation and did not respond to rumours.

AstraZeneca's US-listed shares lifted 4pc on the news, which was first reported by Bloomberg.

[philanderer] 14/7/2017 22:06

According to Bloomberg Pascal's staying...... AZN in the USA. +4%

[stevenrevell] 14/7/2017 10:14

Markets no something

[utyinv] 14/7/2017 10:05

Aren't the Int results out soon?

I know the reasons for the CEO rumoured to leave but shares normally rise into results, is there something that we don't know??

[philanderer] 13/7/2017 12:34

Citi comment:

In the event the CEO's departure is confirmed. Mene Pangalos, current head of AZN research and early development is the highest probability internal candidate, as well as Sean Bohen (CMO), in our view. We also suspect AZN's board has identified additional external candidates as part of the succession planning process.

[scallywagkid] 13/7/2017 09:42

If Company was aware of share price sensitive news listing regulations would require them to update Market immediately. Concern is delay in responding to Soriot news and share price movement which suggests an internal battle to persuade Soriot to stay. However, regulations will come into play and force a clarification. Either he stays or AZN rudderless while industry deckchairs realigned - perfect window for opportunist offer!

[ganthorpe] 13/7/2017 09:15

Agree with Phil - thought his leaving would be a plus not a disaster. Unless he is leaving a few skeletons in the cupboard? Not a golden reign

[stevenrevell] 13/7/2017 09:14

I think we may get another drop soon and hopefully a bargain

[billytkid2] 13/7/2017 08:58

I think the market is making a link between him leaving and the imminent massive news on the lung cancer drug.

[philanderer] 13/7/2017 08:42

Cavalry to the rescue ;-)


13th july Citigroup buy tp 6000p
13th july Liberum buy tp 5500p

reiterations.

[philanderer] 13/7/2017 08:40

Is this fella really worth 4% of the market cap !!

[drectly] 13/7/2017 00:52

explains the late 3% drop in the States, thanks for the info.

[philanderer] 13/7/2017 00:32

So back under 5000p in the morning then ?

[philanderer] 12/7/2017 09:05

12th july Jefferies hold tp 5300p cut from 5500p